Total Payments
$19,949
2024 Payments
$11,415
Companies
9
Transactions
77
Medicare Patients
4,111
Medicare Billing
$253,243
Payment Breakdown by Category
Other$8,835 (44.3%)
Consulting$7,500 (37.6%)
Travel$1,911 (9.6%)
Food & Beverage$1,704 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,835 | 9 | 44.3% |
| Consulting Fee | $7,500 | 4 | 37.6% |
| Travel and Lodging | $1,911 | 11 | 9.6% |
| Food and Beverage | $1,704 | 53 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MIMEDX Group, Inc. | $11,227 | 15 | $0 (2024) |
| ABBVIE INC. | $7,528 | 49 | $0 (2024) |
| Becton, Dickinson and Company | $900.00 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $135.40 | 6 | $0 (2024) |
| PFIZER INC. | $54.01 | 1 | $0 (2017) |
| GENZYME CORPORATION | $46.02 | 2 | $0 (2024) |
| LEO Pharma Inc. | $22.45 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $19.30 | 1 | $0 (2024) |
| Dermavant Sciences, Inc. | $16.80 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,415 | 24 | MIMEDX Group, Inc. ($11,227) |
| 2023 | $128.95 | 2 | AbbVie Inc. ($97.16) |
| 2022 | $1,119 | 16 | Becton, Dickinson and Company ($900.00) |
| 2021 | $52.73 | 4 | AbbVie Inc. ($38.63) |
| 2019 | $3,139 | 10 | AbbVie, Inc. ($3,139) |
| 2017 | $4,095 | 21 | AbbVie, Inc. ($4,017) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $379.17 | General |
| 12/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $379.17 | General |
| 12/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $276.25 | General |
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $325.00 | General |
| 10/30/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $18.26 | General |
| 10/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $116.98 | General |
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 09/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,200.00 | General |
| 09/18/2024 | MIMEDX Group, Inc. | — | Travel and Lodging | Cash or cash equivalent | $134.93 | General |
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Dermatology | ||||||
| 07/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,787.50 | General |
| 07/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $325.00 | General |
| 07/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $81.25 | General |
| 07/18/2024 | MIMEDX Group, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $81.25 | General |
| 07/18/2024 | MIMEDX Group, Inc. | — | Travel and Lodging | Cash or cash equivalent | $30.15 | General |
| 06/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $141.83 | General |
| 05/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Dermatology | ||||||
| 01/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,117 | 1,785 | $211,779 | $67,419 |
| 2022 | 15 | 1,039 | 1,679 | $190,714 | $67,038 |
| 2021 | 14 | 995 | 1,647 | $160,277 | $59,258 |
| 2020 | 13 | 960 | 1,592 | $179,254 | $59,528 |
Total Patients
4,111
Total Services
6,703
Medicare Billing
$253,243
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 266 | $38,104 | $15,909 | 41.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 107 | $21,739 | $8,282 | 38.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 208 | 236 | $38,940 | $7,826 | 20.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 104 | 116 | $22,343 | $7,310 | 32.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 102 | 116 | $26,216 | $7,130 | 27.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 84 | 84 | $15,036 | $5,476 | 36.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $10,356 | $3,504 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $9,964 | $3,491 | 35.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 155 | 682 | $9,548 | $3,084 | 32.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 21 | $7,161 | $1,972 | 27.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 33 | $3,399 | $1,228 | 36.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $6,513 | $1,200 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 27 | $2,364 | $980.03 | 41.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 34 | $95.70 | $25.14 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 205 | $24,980 | $12,396 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 126 | $22,080 | $10,746 | 48.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 93 | 109 | $24,271 | $7,847 | 32.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 106 | 121 | $22,264 | $7,281 | 32.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 181 | 211 | $34,399 | $6,957 | 20.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 63 | 63 | $11,169 | $4,369 | 39.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 16 | 17 | $10,352 | $3,882 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $8,936 | $3,733 | 41.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 126 | 622 | $8,546 | $2,977 | 34.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 20 | $6,676 | $1,795 | 26.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 38 | $2,804 | $1,437 | 51.2% |
About Dr. Dylan Alston, DO
Dr. Dylan Alston, DO is a Dermatology healthcare provider based in Riverton, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1457790180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dylan Alston, DO has received a total of $19,949 in payments from pharmaceutical and medical device companies, with $11,415 received in 2024. These payments were reported across 77 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,835).
As a Medicare-enrolled provider, Alston has provided services to 4,111 Medicare beneficiaries, totaling 6,703 services with total Medicare billing of $253,243. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Riverton, UT
- Active Since 06/15/2013
- Last Updated 07/11/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1457790180
Products in Payments
- Humira (Biological) $6,175
- RINVOQ (Biological) $280.21
- COSENTYX (Drug) $97.82
- EUCRISA (Drug) $54.01
- SKYRIZI (Biological) $52.26
- DUPIXENT (Biological) $46.02
- HUMIRA (Biological) $39.83
- COSENTYX (Biological) $23.48
- ADBRY (Biological) $22.45
- TREMFYA (Drug) $19.30
- VTAMA (Drug) $16.80
- ILARIS (Biological) $14.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.